Irene de Cara Torres

Irene de Cara Torres

Irene de Cara Torres is Head of International Policy, Advocacy and Government Affairs, CSL

Critical Medicines Act: Ensuring Steady Supply of Plasma-Derived Therapies Partner Content
29 Oct Member States
Critical Medicines Act: Ensuring Steady Supply of Plasma-Derived Therapies
The Critical Medicines Act (CMA) must deliver crisp, coordinated action at EU level, paired with national policies that boost plasma donations, streamline medicine distribution, and safeguard competitiveness. Only by aligning resilience with agility and economic viability can Europe secure long-term access to plasma-derived therapies for patients who depend on them.